A group of people talking

Your first step to partnering with us

Contact us

Our partnering leadership team

Our leadership team is integrated and designed for early input from our experts in business development, R&D and commercial. Our team has extensive experience in identifying synergistic opportunities which are complementary to our capabilities and facilitating successful collaborations through effective alliance management.

Our dedicated business development teams are responsible for scouting for late-stage opportunities as well as facilitating the transactional aspects of the deal. Our R&D strategy teams are tasked with sourcing innovation from both inside and outside the organisation, particularly for pre-Phase IIb assets, and are involved in the evaluation process of all deals from day one.

If you want to discuss how we can help you to leverage your regional commercial capabilities, please contact our regional and corporate business development team. Our Venture Capital Interaction Team (VCIT) is focused on proactively interacting with VCs.

Our key partnering contacts

Areas of interest

Cardiovascular & Gastrointestinal (CVGI)

Small molecule business developmentR&D Strategy HeadBiologics business development
Christoph Pittius

VP SPBD, CVGI

James Hall

VP Strategy, CVGI

Eric Victory

VP, Corporate Development

Oncology 

Small molecule business developmentR&D Strategy HeadBiologics business development

Gaynor Fryers

VP SPBD, Oncology, PHB and STL

Detlev Biniszkiewicz

VP Strategy, Oncology

Tracey Vetterick

Director, Business Development

Respiratory and inflammation (R&I)

Small molecule business developmentR&D Strategy HeadBiologics business development

Joanne Kelly

VP SPBD, R&I and New Opportunities

Rose Maciewicz

VP Strategy, R&I

Jennifer Ma

Associate Director, Business Development

Infection

Small molecule business developmentR&D Strategy HeadBiologics business development

Karen Gallant

VP SPBD, Infection

Jacques Dumas

VP Strategy, Infection

Jennifer Ma

Associate Director, Business Development

Neuroscience

Small molecule business developmentR&D Strategy HeadBiologics business development

Tim Herpin

VP SPBD, Neuroscience

Frank Yocca

VP Strategy, Neuroscience

Christina Griffin

Senior Manager, Business Development

New opportunities

Small molecule business developmentR&D Strategy HeadBiologics business development

Mark Rogers

Business Development Director
& Venture Capital Co-ordinator

Robert Ward

VP Strategy, New Opportunities

John Trainer

Senior Director, Business Development

Personalised Healthcare & Biomarkers (PHB)

Small molecule business developmentR&D Strategy HeadBiologics business development

Cecilia Schott

Executive Business Development Director, Personalised Healthcare

Glenn Miller

VP Strategy, PHB

John Trainer

Senior Director, Business Development

Science & Technology (STL)

Small molecule business developmentR&D Strategy HeadBiologics business development

Campbell Wilson

Executive Business Development Director, STL

n/a

John Trainer

Senior Director, Business Development

Regional and corporate business development

Russell Gantt

VP Regional and Corporate Business Development

Russell.Gantt@astrazeneca.com

Denise E Goode

Executive Director, Regional & Corporate Business Development

Denise.Goode@astrazeneca.com

Jeanette Evans

Executive Director, Regional & Corporate Business Development

Jeanette.Evans@astrazeneca.com

Mahmood Ladha

Executive Director, Regional & Corporate Business Development

Mahmood.Ladha2@astrazeneca.com

 

Europe, Middle East, Africa

Geoff Collett
Regional Business Development Director

Geoff.Collett@astrazeneca.com

Håkan Wickholm
Regional Business Development Director

Hakan.Wickholm@astrazeneca.com

USA, Latin America

Carlos Garrido
Regional Business Development Director

Carlos.Garrido@astrazeneca.com

Asia Pacific

Augustine Yee
Regional Business Development Director

Augustine.Yee@astrazeneca.com

Japan

Kimio Nishimura
Regional Business Development Director

Kimio.Nishimura@astrazeneca.com

Venture Capital enquiries

AreaKey Contact
All enquiries

Mark Rogers
Business Development Director & Venture Capital Co-ordinator

Mark.V.Rogers@astrazeneca.com

Download our brochure

Download

New for 2012, download your comprehensive guide to partnering with AstraZeneca.